Clinical trial

"FEXIS": (Feasibility of an Extended Wear CSII Set in Participants With T1DM)

NCT04503564

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DEVICE · Unmapped registry intervention coil-reinforced soft polymer indwelling cannula Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

"FEXIS": (Feasibility of an Extended Wear CSII Set in Participants With T1DM)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-11-13

PhaseNA

Conditions

Diabetes Mellitus, Type 1candidate · MONDO: type 1 diabetes mellitus

Type 1 Diabetesverified · MONDO: type 1 diabetes mellitus

Type 1 Diabetes Mellitusverified · MONDO: type 1 diabetes mellitus

Diabetes Mellitus, Insulin-Dependent, 1verified · MONDO: type 1 diabetes mellitus 1

Interventions

coil-reinforced soft polymer indwelling cannulaDEVICE

Sponsors & collaborators

Capillary Biomedical, Inc.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04503564 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.